BioScrip, Inc., the specialty pharmacy and pharmacy services provider, had a double dose of good news today with the announcement of exceptional second quarter revenue and earnings figures. Consolidated revenue grew to $348.4 million, an 18.2% increase over the same period last year. Specialty Services revenue shot up to $298.2 million, a 25.3% over the prior year. Even more impressive was quarterly net income, which grew to $1.6 million, compared to $.5 million last year. Net income was helped along by the company’s healthy control over operating expenses, which shrunk as a percentage of revenue to 9.3% from 10.3% over the same period a year ago.

BioScrip’s Chairman and CEO, Richard H. Friedman, stated, “Our second quarter results, including a $3.2 million sequential increase in quarterly operating income, demonstrate our positive sales growth trends and the significant progress we have made toward improving our operating performance. As we work to

Sharps Compliance Corp. announced record revenues for the first quarter of fiscal 2009. Revenues jumped 26%, to $4.3 million, from the same quarter last year. Sharps also reported record customer billings of $4.7 million for the quarter, a 30% increase over the same period the year before.

The increase in billings came partly from contracts and patent renewals with pharmaceutical manufacturers, which are expected to continue contributing to billings and revenue growth in fiscal 2009. In addition, customer billings to retail markets increased 23% as a result of strong flu-season demand for the Sharps Disposal By Mail Systems®. There were also higher billings to the professional, commercial, and agricultural markets. The only billing declines were in the healthcare and hospitality markets.

Gross profit was $1.8 million, up 29% over the prior year period. Gross margin was 43.3% in the first quarter of fiscal 2009, a 100 basis point increase compared

BioScrip Inc. (Nasdaq: BIOS) is a pharmaceutical healthcare organization that provides medications and management solutions for pharmacies and other related healthcare venues in the United States. The company operates through its Specialty Services and PBM Services segments. As of December 31, 2007, BioScrip operated 40 pharmacies in the United States, including community, mail and infusion pharmacies.

The company recently received a “Buy” rating from Noble Financial, with a price target of $6.50. The firm expects 9.5-10 percent revenue growth, as well as more than 50 percent earnings per share growth over the next three years. BioScrip can achieve this through the likely “significant capture of efficiencies.”

The specialty pharmacy industry is a rapidly growing market, enhanced by its convenient location features across metropolitan areas. For health, transportation or other issues, patients are finding mail delivered prescriptions a quick, cost-effective way to obtain prescriptions.

BioScrip offers both of these services, as well

ALR Technologies, Inc. (ALRT.OB) primarily engages in designing, marketing, and distributing medical reminder compliance devices. The company uses technology-based products that aid people in achieving improved health and improved well-being. ALR Technologies is known as a pioneer and leader in the compliance management sector of the disease management industry.

ALR Technologies is focused on providing a product that reminds patients to take their medication or treatment at the prescribed time. The company offers ALRT Med Reminder, ALRT Once-A-Day, ALRT Weekly, ALRT Contact Lens Replacement and ALRT PC200. Each product can be programmed by the user for specific time duration reminders. The company’s well-known product, Constant Health Companion, reminds the user of the time to take medication and it displays the actions or medications necessary to take with that specific reminder. ALR Technologies’ product offering ranges from portability, display on LCD screens, and pet medication reminders.

ALR Technologies is based in Winston-Salem, North